Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
All APAC Global
All APAC Global
All APAC Global
All APAC Global
New CAS BioFinder Discovery Platform empowers drug discovery scientists to reveal insights, drive innovation, and save time 2024-05-21 21:00
Complete Genomics expands to East Coast with new Customer Experience Center in Greater Boston's Biotech Hub 2024-05-21 21:00
Etiometry Awarded Frost & Sullivan's 2024 North American Enabling Technology Leadership Award for Leading Innovation in Clinical Decision Support Systems 2024-05-21 20:00
Ractigen Therapeutics Secures FDA Fast Track Designation for RAG-01, a First-in-Class saRNA Therapy 2024-05-21 20:00
Cali Biosciences Announces Publication of Successful Phase 2 Study Results in Hernia 2024-05-21 17:52
RemeGen Completes Patient Enrollment in Two Phase III Clinical Trials Using Telitacicept for Treatment of IgA Nephropathy and Primary Sjögren's Syndrome 2024-05-21 17:35
Dignitana signs an exclusivity agreement for Japan with Konica Minolta 2024-05-21 16:43
BGI Team Successfully Reaches the Summit of Mount Everest 2024-05-21 16:41
NUS scientists discover a novel way of activating muscle cells' natural defences against cancer using magnetic pulses 2024-05-21 16:35
Simcere Phar-maceuticals Presented Six Studies on Sanbexin® at ESOC 2024 2024-05-21 15:52
GC Biopharma/Novel Pharma's Sanfilippo Syndrome Treatment Obtains FDA IND Clearance 2024-05-21 15:12
ZYMFENTRA™ (infliximab-dyyb) demonstrated long-term efficacy and safety profile of maintenance treatment through two years for adults with moderately to severely active Crohn's disease and ulcerative colitis 2024-05-21 12:01
ILJIN SNT Co., Ltd. Calls for Board Restructure at Aurinia Pharmaceuticals 2024-05-21 09:49
Innovent Announces the New Drug Application of IBI311 (IGF-1R antibody) has been Accepted by the NMPA of China for Thyroid Eye Disease 2024-05-21 08:55
Telix Completes Proof-of-Concept Study of TLX592 Targeted Alpha Therapy in Prostate Cancer 2024-05-21 07:58
Pierre Fabre Laboratories announces the submission by Atara Biotherapeutics of Tabelecleucel (Tab-cel®) Biologics License Application for treatment of Epstein-Barr Virus Positive Post-Transplant Lymphoproliferative Disease with U.S FDA 2024-05-20 21:30
Lunit Achieves Historic Milestone: 100 Peer-Reviewed Papers Published on Its AI Medical Imaging Suite 2024-05-20 21:00
Duoning Collaborates with Bioelectronica to Commercialize a Single-Cell Sorting System for Antibody Discovery 2024-05-20 20:00
HaemaLogiX welcomes former Australian Federal Minister for Health Professor the Hon Greg Hunt to the company board as Non-Executive Director 2024-05-20 18:00
TREEFROG PRESENTS DATA FROM THEIR PARKINSON'S DISEASE CELL THERAPY PROGRAM AT THE 29TH WORLD CONGRESS ON PARKINSON'S DISEASE AND RELATED DISORDERS (IAPRD) IN LISBON 2024-05-20 14:30
1 64 65 66 67 68 962